|Title:||The afsumb consensus statements and recommendations for the clinical practice of contrast-enhanced ultrasound using sonazoid||Authors:||Lee J.Y.
|Keywords:||Consensus; Contrast media; Liver; Pancreatobiliary; Sonazoid; Ultrasonography||Issue Date:||2020||Publisher:||Korean Society of Ultrasound in Medicine||Journal Volume:||39||Journal Issue:||3||Start page/Pages:||191-220||Source:||Ultrasonography||Abstract:||
The first edition of the guidelines for the use of ultrasound contrast agents was published in 2004, dealing with liver applications. The second edition of the guidelines in 2008 reflected changes in the available contrast agents and updated the guidelines for the liver, as well as implementing some nonliver applications. The third edition of the contrast-enhanced ultrasound (CEUS) guidelines was the joint World Federation for Ultrasound in Medicine and Biology-European Federation of Societies for Ultrasound in Medicine and Biology (WFUMB-EFSUMB) venture in conjunction with other regional US societies such as Asian Federation of Societies for Ultrasound in Medicine and Biology, resulting in a simultaneous duplicate on liver CEUS in the official journals of both WFUMB and EFSUMB in 2013. However, no guidelines were described mainly for Sonazoid due to limited clinical experience only in Japan and Korea. The new proposed consensus statements and recommendations provide general advice on the use of Sonazoid and are intended to create standard protocols for the use and administration of Sonazoid in hepatic and pancreatobiliary applications in Asian patients and to improve patient management. ? 2020, Korean Society of Ultrasound in Medicine. All rights reserved.
|ISSN:||2288-5919||DOI:||10.14366/usg.20057||SDG/Keyword:||contrast medium; perflubutane; adenoma; Article; bile duct carcinoma; chemoembolization; clinical evaluation; clinical practice; consensus development; contrast-enhanced ultrasound; disease surveillance; echography; gallbladder disease; hemangioma; human; image analysis; information processing; liver abscess; liver biopsy; liver carcinogenesis; liver cell carcinoma; liver cirrhosis; liver injury; lymphoma; metastasis; nodular hyperplasia; patient care; pharmacokinetics; practice guideline; qualitative analysis; quantitative analysis; radiofrequency ablation; signal processing; three dimensional echography; treatment response; tumor ablation
|Appears in Collections:||醫學系|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.